Additionally, by targeting SLITRK5 or modulating its activity, researchers may be able to develop new therapeutic strategies for treating melanoma and potentially other cancers that involve dysregulation of the Hedgehog signaling pathway. Here, SLITRK5 is linked to melanoma.